Your cholesterol & full lipid panel — a practical guide

Below you’ll find the essence of how to read your results, what truly improves them, and how to implement changes in 5 steps — based on aligned guidelines (ESC/EAS, ACC/AHA), AHA/WHO statements, EFSA reviews and reviews on remnant cholesterol (e.g., PMC).

Share on X

Your lipid panel, without jargon

  • LDL-C — cholesterol carried in LDL particles. It is one of the main causes of atherosclerosis. The higher your cardiovascular risk, the lower your LDL target should be. There is no single “good” value for everyone. ESC/EAS 2025
  • HDL-C — often called “good cholesterol”. Low HDL can accompany poorer metabolic health, but raising HDL itself with medication is not a treatment goal. LDL, the number of harmful particles and total risk matter more. ESC/EAS
  • TG (triglycerides) — fats circulating in blood. Good <150 mg/dL; borderline/high 150–499; very high ≥500 (pancreatitis risk → urgent management). ACC
  • TC (total cholesterol) — supportive only; LDL-C and the indices below are more informative. ESC/EAS

Key LDL targets depend on risk

  • Low risk: usually an LDL-C target below 116 mg/dL.
  • Moderate risk: usually below 100 mg/dL.
  • High risk: below 70 mg/dL and at least a 50% reduction from baseline.
  • Very high risk (for example established atherosclerosis or a previous heart attack): below 55 mg/dL and at least a 50% reduction.

Important: risk depends on age, blood pressure, smoking, diabetes, kidney disease, previous cardiovascular events and additional risk factors. LDL alone does not define your target.

Additional markers and useful calculations

  • non-HDL-C = TC − HDL-C. It captures all particles that can contribute to atherosclerosis. Its target also depends on risk and is usually about 30 mg/dL higher than the matching LDL target. ESC/EAS
  • Remnant cholesterol (RC) = TC − LDL-C − HDL-C. This calculated value can point to additional risk when triglycerides are high, but it should not be interpreted on its own. PMC
  • TG/HDL ratio: can be a supporting clue to poorer metabolic health, but it does not diagnose insulin resistance and has no single cut-off that works for everyone. PMC
  • ApoB (apolipoprotein B): estimates the number of atherogenic particles. The 2026 AHA/ACC guideline highlights selective ApoB testing particularly with TG >200 mg/dL, diabetes, or very low achieved LDL-C, when the standard lipid profile may underestimate residual lipoprotein-related risk. AHA/ACC 2026
  • Lp(a), or lipoprotein(a): is a largely inherited risk factor. ESC/EAS 2025 and AHA/ACC 2026 support measuring it at least once in adulthood. ESC/EAS uses >105 nmol/L (50 mg/dL) as a risk modifier; AHA/ACC identifies ≥125 nmol/L as risk-enhancing and notes that ≥250 nmol/L is associated with roughly twice the estimated ASCVD risk. A high result supports more intensive LDL-C and overall risk-factor management. ESC/EAS 2025 AHA/ACC 2026

Why this matters

It’s not only correlation: LDL-C causes atherosclerosis — confirmed by genetics, observational cohorts and hundreds of randomized trials. Lowering LDL reduces MI/stroke risk, and long-term exposure to high LDL accumulates lifetime risk. Remnants add risk even with “decent” LDL. PMC

What works best — simple, effective, no gimmicks

1) Food: change the type of fat, not just “eat less fat”

Saturated fats
Saturated fats (SFA) are found mainly in butter, lard, fatty meat, full-fat cheese, cream, palm fat and coconut fat. They do not need to be eliminated completely; what matters most is what replaces the excess.
→ swap to →
Unsaturated fats
Unsaturated fats are found in olive oil, canola/rapeseed oil, nuts, seeds and fish. When they replace part of the butter, lard and fatty meat in a diet, they usually help lower LDL.
Canola/rapeseed oil
Human studies do not support the claim that normal canola/rapeseed oil intake causes inflammation. In controlled trials, replacing some animal fat with canola oil generally lowered LDL. This does not mean adding large amounts of oil to the diet. RCT meta-analysis

Use olive oil as the main choice and canola/rapeseed oil as a reasonable alternative. Do not overheat oil, let it smoke or reuse the same frying oil repeatedly.

What to prioritise (everyday pattern):

  • First choice: olive oil, especially extra virgin. Reasonable alternative: canola/rapeseed oil. There is no need to add sunflower oil specifically for health.
  • Nuts & seeds (almonds, walnuts, flax, sesame) as snack swaps for sweets/processed snacks.
  • Fish 2×/week (salmon, mackerel, herring, sardines).
  • Plenty of vegetables/legumes/whole grains — a Mediterranean-style, minimally processed pattern.
  • Limit: fatty processed meats, full-fat cheeses/butter, ultra-processed sweets and refined carbs.

What this means in the kitchen: instead of using butter on bread every day and frying in large amounts of animal fat, use olive oil more often, a small amount of canola/rapeseed oil, or choose a handful of nuts. This type of swap usually lowers LDL; the exact effect depends on the whole diet and the amount of fat eaten. AHA

2) Soluble (gel-forming) fibre — daily, from concrete sources

  • ≈3 g/day β-glucan from oats/barley lowers LDL by ~5–7%. Psyllium (5–10 g/day) similar. EFSA PMC
  • Best sources: oats/bran, barley, psyllium husk, legumes (lentils/beans/chickpeas).

3) Phytosterols — in foods + optional fortified products

  • 1.5–2.4 g/day lowers LDL ~7–10%. Rich foods: vegetable oils (sesame/rice bran/corn/canola), sesame, sunflower, wheat germ; fortified spreads/yogurts help reach 2 g/d. EFSA NCBI
  • Fortified products work best with a meal. They do not replace medication. They are not intended for young children or for pregnancy/breastfeeding without individual advice; the rare condition sitosterolaemia is a contraindication.

4) Activity “by the watch”

  • 150–300 min/week moderate or 75–150 min vigorous + 2× strength: TG ↓, HDL ↑, sometimes LDL ↓; consistency is key. WHO

5) High-impact basics

  • Weight ↓ (if excess): strongest effect on TG and non-HDL-C. ACC
  • Alcohol & simple sugars ↓: fastest way to lower TG. ACC
  • Stop smoking: HDL improves and overall risk drops. AHA
  • Exclude secondary causes (e.g., hypothyroidism, some meds). ESC/EAS

2025–2026 guideline update

What changed: ESC/EAS 2025 retained risk-based LDL-C goals, gave greater weight to Lp(a), CAC and subclinical atherosclerosis as risk modifiers, and strengthened the role of bempedoic acid. AHA/ACC 2026 brings back LDL-C and non-HDL-C treatment goals, recommends at least one lifetime Lp(a) measurement and selective ApoB testing. Supplements and vitamins are not recommended as a strategy to lower LDL-C and ASCVD risk.

Newer sources: ESC/EAS Focused Update 2025; AHA/ACC Dyslipidemia Guideline 2026.

When diet may not be enough

Diet and activity are the foundation, but people with high risk or markedly raised LDL often also need medication. Treatment commonly starts with a statin. If the effect is not enough or the drug is not tolerated, a clinician may consider ezetimibe, bempedoic acid or PCSK9-targeting medicines. Treatment depends on total risk, not one number.

Useful checks: blood pressure, glucose or HbA1c, TSH (thyroid), kidney and liver function, current medicines, ApoB and Lp(a). After a meaningful lifestyle or medication change, lipids are commonly rechecked after about 6–12 weeks.

Check your lipid panel — Calculator

Enter the four values exactly as shown on your report. The calculator works out non‑HDL cholesterol and remnant cholesterol, then explains the numbers in plain language.

Enter your lipid panel results

Enter all values in mg/dL. Age and weight are not needed for these calculations.

Also shown as TC or CHOL
Shown as LDL‑C
Shown as HDL‑C
Shown as TG

Calculations happen on your device. Your entries are not sent or stored. This is general guidance, not a diagnosis or treatment recommendation.

Sources & further reading

← Back to Health